Other

Dataset Information

0

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors [Cut&Run]


ABSTRACT: Fusion-positive rhabdomyosarcoma (FP-RMS) driven by the expression of the PAX3-FOXO1 (P3F) fusion oncoprotein is an aggressive subtype of pediatric rhabdomyosarcoma. FP-RMS histologically resembles developing muscle yet occurs throughout the body in areas devoid of skeletal muscle highlighting that FP-RMS is not derived from an exclusively myogenic cell of origin. Here we demonstrate that P3F reprograms mouse and human endothelial progenitors to FP-RMS. We show that P3F expression in aP2-Cre expressing cells reprograms endothelial progenitors to functional myogenic stem cells capable of regenerating injured muscle fibers. Further, we describe a FP-RMS mouse model driven by P3F expression and Cdkn2a loss in endothelial cells. Additionally, we show that P3F expression in TP53-null human iPSCs blocks endothelial-directed differentiation and guides cells to become myogenic cells that form FP-RMS tumors in immunocompromised mice. Together these findings demonstrate that FP-RMS can originate from aberrant development of non-myogenic cells driven by P3F.

ORGANISM(S): Homo sapiens

PROVIDER: GSE241644 | GEO | 2023/09/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-09-30 | GSE241645 | GEO
2023-09-30 | GSE218265 | GEO
2023-09-30 | GSE218254 | GEO
2024-03-05 | GSE260915 | GEO
2021-04-01 | GSE162052 | GEO
2024-10-25 | GSE279335 | GEO
2024-10-25 | GSE279336 | GEO
2020-11-20 | MSV000086494 | MassIVE
2021-02-22 | GSE119716 | GEO
2013-12-31 | E-GEOD-28511 | biostudies-arrayexpress